National Science Foundation

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

CenSyn is a brain health screening platform focused on enhancing the accessibility and efficiency of diagnosing various neurological conditions. The company has developed a handheld EEG monitoring device aimed at accelerating the screening process for Alzheimer's, traumatic brain injury, and epilepsy. Their proprietary software facilitates long-term management of brain health by allowing clinicians to wirelessly monitor and record brain electrical activity in real time. This innovative approach enables the rapid detection of altered mental status, supporting timely diagnosis and immediate treatment, ultimately reducing inpatient costs and improving care for diverse patient populations.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

ProMedix is a medical device startup founded in 2019 and headquartered in Portland, Oregon. The company specializes in developing noninvasive, fingertip patient monitors aimed at enhancing the recognition of circulatory dysfunction. Its innovative devices facilitate diagnostic evaluations and the monitoring of therapeutic interventions for various medical conditions, such as trauma, dehydration, and sepsis. By improving home patient monitoring, ProMedix enables physicians to streamline care in both home and critical settings, thereby preventing unnecessary acute visits and enhancing emergency or critical care outcomes.

Claria Medical is a pre-commercial medical device start-up focused on developing innovative solutions for women's healthcare, specifically targeting unmet needs in gynecologic surgery. The company specializes in creating minimally invasive surgical tools designed to enhance procedures such as hysterectomy and myomectomy. Claria Medical has received recognition for its early achievements, including a “Safer Technologies Designation” from the U.S. Food and Drug Administration. Additionally, the company has secured funding through private investments as well as grants from the National Science Foundation and the National Institutes of Health to support its product development efforts. By providing specialized surgical assistance, Claria Medical aims to improve outcomes for women undergoing these procedures.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

PHAXTEC provides natural material solutions to serve the foodservice packaging, agriculture, and personal care industries. Their PHA biopolymers are biodegradable in soil, freshwater, and marine environments like cellulose or paper.

HairDays is an AI-powered health data company that has developed a unique hair intelligence platform focused on simplifying hair classification and care. The platform provides tailored recommendations for maintaining healthy hair, allowing consumers to discover and purchase hair care products suited to their individual needs. By curating relevant content, HairDays enables users to monitor their hair conditions and track their growth progress effectively. This innovative approach eliminates the guesswork often associated with hair care, empowering individuals to make informed decisions about their hair health.

Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.

UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.

Our mission is to promote innovation that empowers people to have the knowledge and tools to solve everyday medical problems in any setting. We do this by providing a doctor’s approach to stopping nosebleeds at your fingertips. Bleed Freeze allows people to confidently take control and treat nosebleeds anywhere.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Liv Labs is a consumer health technology company focused on enhancing pelvic floor fitness for women globally. The company offers an affordable pelvic floor fitness kit designed to help manage urinary leakage during various physical activities. By providing convenient solutions, Liv Labs aims to empower women to control urinary leaks and restore natural continence, promoting overall health and well-being.

Quadralynx provides wearable biometric devices for adults with motor speech disorders, especially those with volume control issues due to Parkinson’s disease and related neurological disorders. Their device alerts the user via a vibration of a pathological voice state.

EchoWear develops a smartwatch-based system designed to improve access to healthcare through digital health services. Their system offers thoughtful engagement with patients and care teams to create actionable digital health services, enabling users to experience age-friendly health technologies.

Pragma Health provides digital healthcare services. They permit users to perform different tests for cardiovascular, hematology, infectious diseases, and others in the privacy of their home and provide accurate, immediate results, enabling them to get a convenient, cost-effective, and accurate healthcare testing process.

Empo Health specializes in in-home health monitoring solutions that enhance patient care by integrating seamlessly into daily life. The company has developed an innovative imaging bathroom scale and a digital health platform aimed at detecting early signs of diabetic foot conditions, thereby helping to prevent amputations. By providing reliable visual data outside of clinical settings, Empo Health enables both patients and clinicians to monitor health effectively and maintain standards of care. Through its advanced technology, the company seeks to improve health outcomes and foster proactive management of chronic conditions.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

Notus Labs offers wearable devices that allow people to monitor their health and performance remotely and non-invasively. Using their products, physicians and individuals can optimize triaging in cases of sudden physiological deterioration by receiving a comprehensive and continuous summary of their vitals. By preventing overexertion injuries and heat-related illnesses, users can maximize physical performance growth while reducing the risk of overexertion injuries and heat-related illnesses.

Immersive Reality Group uses artificial intelligence-enabled technology to provide personalized healthcare solutions. The company was founded in 2004 and is headquartered in Bozeman, Montana.

SweatID is a developer of wearable fabric sensors designed for health and fitness applications. Their sensors help to monitor hydration on the surface of the skin in real time, enabling users to continuously monitor biomarkers.

Quick-Med Technologies, Inc. is a life sciences company dedicated to developing proprietary technologies aimed at infection prevention and control in both medical and consumer healthcare markets. Founded in 1997 and headquartered in Gainesville, Florida, the company specializes in biomedical products and devices with antibacterial applications. Its core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a series of advanced polymers with antimicrobial and hemostatic properties; Stay Fresh, a chemical formulation for textiles that provides durable antimicrobial protection; and MultiStat, which comprises patented methods and compounds for skin therapy. Quick-Med serves a diverse range of clients, including government agencies, healthcare providers, and companies in the apparel, textile, and personal care sectors.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Active Therapy Systems develops an interactive exercise platform to deliver in-home therapies to people living with Parkinson's disease. The company was founded in 2017 and is headquartered in Nicholasville, Kentucky.

Proov offers patented at home testing systems - including the only FDA cleared at-home test to measure progesterone metabolite PdG - to help women understand and act on their hormones. When used with the Proov Insight app, Proov's easy, at-home pee tests provide a science-backed fertility coach right in your hand. First, a woman can measure all of the menstrual hormones daily with Proov tests, then snap a photo of each test within the Insight app. Then, a woman can follow the in-app prompts throughout her cycle to understand ovulation status, get daily insights and an Ovulation Insights score. Finally, the app generates a personalized action plan to maximize her wellness or develop a fertility strategy. Proov was founded by Amy Beckley, Ph.D, the "infertile scientist," after three years of infertility and seven miscarriages. Amy applied her own science expertise to uncover a luteal phase defect (a problem with ovulation quality). With help from her doctor and a simple supplement, Amy was able to get pregnant with her daughter. Proov is a venture capital backed company and the leader in understanding hormone health on the basis of tracking PdG, a metabolite of progesterone.

Progenitor MDX is engaged in developing cellular immunotherapy technologies that facilitate the creation of induced pluripotent stem cells for use in immune-oncology and engineered cell therapies. The company combines all Yamanaka factors into a single vector, enabling simple and reliable cellular reprogramming. This innovation supports the efficient production of allogeneic off-the-shelf CAR constructs derived from various cell sources. In addition to its focus on cellular immunotherapy, Progenitor MDX offers a comprehensive and customizable solution for managing COVID-19 infections, which includes providing testing results and actionable plans for infection management to support community health.

BiomeSense, Inc. is a company that specializes in developing an integrated platform combining hardware, software, and data analytics to enhance the collection and analysis of microbiome data in clinical research. Founded in 2018 and based in Chicago, Illinois, BiomeSense has created the GutLab, an innovative "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology, along with the MetaBiome time-series analytics platform, provides a comprehensive solution that enables researchers, patients, and consumers to track microbiome changes in real time and understand their impact on health outcomes. By generating and analyzing large-scale, longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, ultimately improving precision medicine and the development of microbiome-based therapeutics and products.

Lasarrus develops devices for patients with chronic obstructive pulmonary disease. The company was founded in 2013 and is headquartered in Baltimore, Maryland.

Claria Medical is a pre-commercial medical device start-up focused on developing innovative solutions for women's healthcare, specifically targeting unmet needs in gynecologic surgery. The company specializes in creating minimally invasive surgical tools designed to enhance procedures such as hysterectomy and myomectomy. Claria Medical has received recognition for its early achievements, including a “Safer Technologies Designation” from the U.S. Food and Drug Administration. Additionally, the company has secured funding through private investments as well as grants from the National Science Foundation and the National Institutes of Health to support its product development efforts. By providing specialized surgical assistance, Claria Medical aims to improve outcomes for women undergoing these procedures.

Starling Medical focuses on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, integrating seamlessly into everyday bathroom routines. The company is developing a healthcare device that employs mass spectroscopy-based sensors to continuously monitor changes in urine composition. This technology aims to enable early detection of chronic health issues, allowing both patients and healthcare providers to intervene promptly and potentially prevent serious complications or hospitalizations. By offering predictive insights, Starling Medical aspires to enhance health outcomes through proactive monitoring.

Intake Health is a developer of a continuous passive health monitoring device that operates at home without requiring changes in user behavior. The device is designed to be mounted on a toilet, where it automatically tests urine from flush water to deliver lab-quality results for various health and dietary indicators. By leveraging advanced biosensors and wireless technology, the system accurately tracks hydration and nutrition by quantifying specific urinary biomarkers. Users receive instant insights on their health metrics through a mobile application, facilitating informed decision-making regarding their well-being. Intake Health aims to enhance health predictions and personalized prevention strategies through the accumulation of personalized biomarkers over time. The company has received funding from the National Science Foundation and the National Institutes of Health.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.

Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.

UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.

Telling.ai is a telehealth platform focused on assessing lung health through the analysis of voice and breath sounds. By capturing respiratory sounds in real-world settings, the company provides real-time feedback and optimizes data quality to support individuals with chronic lung conditions. Their technology identifies signatures in breath and speech that indicate various medical conditions, including respiratory diseases and infections. Telling.ai aims to assist in the management of care for over 1 billion people suffering from acute or chronic respiratory disorders, enabling timely interventions that can prevent costly hospitalizations and improve overall patient outcomes.

Rizlab Health enables practitioners and patients to acquire full blood count readings in minutes. Founded in 2018 and is based in East Princeton.

Koya Medical, Inc., founded in 2018 and based in Oakland, California, specializes in developing innovative therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. The company focuses on creating wearable technology that delivers active compression therapy, which is designed to enhance movement and mobility for patients. Koya Medical's approach offers a personalized alternative to traditional compression methods, utilizing a sensor-based closed-loop system to provide tailored compression patterns. This technology addresses the needs of patients suffering from conditions such as lymphedema, chronic edema, and chronic venous insufficiency, thereby improving their quality of care and overall treatment outcomes.

Sumaq Life is a software company that identifies patients who qualify for genomic testing and develops personalized treatment plans based on test results and gene regulatory modeling. Their AI approach allows for both single-agent and multi-agent therapy.

Manus Robotics is focused on developing a smart health and wellness device aimed at promoting independent and healthy living. The company offers a wearable robot that assists individuals with disabilities in their daily activities, providing intelligent support to enhance their quality of life. In addition to daily living assistance, the device collects and analyzes muscle data from patients, facilitating rehabilitation efforts and helping users regain independence.

BioLum Sciences LLC, founded in 2015 and based in Dallas, Texas, focuses on developing innovative asthma management devices that enable patients to monitor airway inflammation. The company specializes in bioanalytical chemistry and medical device development, utilizing a chemiluminescent platform to measure biomarkers in exhaled breath condensate and blood samples. Their primary product, the BioSense Airway Monitoring Device (AMD), allows for at-home monitoring of lung function by measuring oxidative stress biomarkers without complicated breathing maneuvers. This technology not only aids patients in tracking their symptoms and medication efficacy but also provides physicians with vital data to optimize treatment plans. Additionally, BioLum’s blood analysis product offers a simple finger-prick test to assess nitric oxide levels and cardiovascular health. The company's initiatives extend to addressing chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), hypertension, and heart failure, supporting both clinicians and researchers in personalizing treatment strategies and improving patient outcomes.

Storx Technologies develops a technology that is dedicated to the health and safety of mothers and babies during labor and delivery.

Viora Health is a health and wellness company focused on advancing health equity among diverse populations. It offers tech-enabled, human-centered programs that utilize social and behavioral engagement to enhance capacity, satisfaction, outcomes, and revenue for healthcare providers. The company is backed by funding from reputable organizations such as the American Heart Association, the National Institutes of Health, Johnson and Johnson, and the National Science Foundation, with its initiatives validated through an Institutional Review Board-approved study. Viora Health's programs have demonstrated a 75% satisfaction score, double retention rates, and improved health outcomes, including reduced stress and better access to food and social support. Additionally, Viora Health develops a healthcare compliance platform aimed at enhancing adherence to diabetes prevention initiatives by connecting patients to programs, tracking data, and facilitating online engagement tools, which help diabetes prevention programs comply with insurance requirements and achieve outcome-based reimbursement.

VitalFlo Inc. is a digital health company based in Raleigh, North Carolina, established in 2017. It specializes in manufacturing handheld spirometers for asthmatic patients, allowing them to monitor their lung health and medication use. In addition to the spirometers, VitalFlo develops software that connects patients with chronic respiratory conditions to their healthcare providers. The company's remote monitoring system tracks lung function and environmental factors that may trigger asthma attacks, providing actionable insights to clinical teams. This innovative approach aims to reduce emergency room visits by offering timely recommendations to patients, thereby redefining asthma management and enhancing overall care.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Lasarrus develops devices for patients with chronic obstructive pulmonary disease. The company was founded in 2013 and is headquartered in Baltimore, Maryland.

HeroWear is a company focused on developing innovative wearable technology designed to enhance worker safety, health, and productivity in physically demanding roles. Their flagship product, the Apex, is a back-assist exosuit specifically engineered for both men and women. This garment aims to alleviate back strain and fatigue while maintaining the comfort of everyday clothing. The Apex incorporates patent-pending dual-mode technology, which allows users to easily toggle back support on and off, making it versatile for various work environments. Additionally, the exosuit's modular textile design offers over 50 customizable combinations, ensuring that it can be tailored to fit the specific needs of any worker engaged in strenuous tasks. Through these advancements, HeroWear aims to reduce physical strain and improve the overall well-being of employees in demanding jobs.

Intake Health is a developer of a continuous passive health monitoring device that operates at home without requiring changes in user behavior. The device is designed to be mounted on a toilet, where it automatically tests urine from flush water to deliver lab-quality results for various health and dietary indicators. By leveraging advanced biosensors and wireless technology, the system accurately tracks hydration and nutrition by quantifying specific urinary biomarkers. Users receive instant insights on their health metrics through a mobile application, facilitating informed decision-making regarding their well-being. Intake Health aims to enhance health predictions and personalized prevention strategies through the accumulation of personalized biomarkers over time. The company has received funding from the National Science Foundation and the National Institutes of Health.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

SweatID is a developer of wearable fabric sensors designed for health and fitness applications. Their sensors help to monitor hydration on the surface of the skin in real time, enabling users to continuously monitor biomarkers.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.

Tanzen Medical, founded in 2017 and located in Severna Park, Maryland, specializes in the development of clinically accurate wearable devices aimed at assessing and enhancing sleep quality in a home setting. The company's innovative technology is designed to aid in the diagnosis of sleep-related disorders, such as ADHD and narcolepsy, by monitoring nightly leg movements. This functionality allows users to track various aspects of their sleep, including quality, position, and arousal, ultimately promoting better sleep health.

Active Therapy Systems develops an interactive exercise platform to deliver in-home therapies to people living with Parkinson's disease. The company was founded in 2017 and is headquartered in Nicholasville, Kentucky.

Plasmonic Diagnostics is a biotechnology company focused on developing innovative diagnostic systems for infectious diseases, sexually transmitted infections, and cancer. Utilizing advanced single molecule detection technology, the company aims to create non-invasive and highly sensitive testing devices that target specific biomarkers. Their offerings include 3D-printed components and a smartphone camera as a detector, allowing for efficient time-to-detection, intrinsic signal amplification, and a high signal-to-noise ratio. This approach not only enhances the accuracy of diagnostics but also aims to make testing more affordable and accessible for patients.

VitalFlo Inc. is a digital health company based in Raleigh, North Carolina, established in 2017. It specializes in manufacturing handheld spirometers for asthmatic patients, allowing them to monitor their lung health and medication use. In addition to the spirometers, VitalFlo develops software that connects patients with chronic respiratory conditions to their healthcare providers. The company's remote monitoring system tracks lung function and environmental factors that may trigger asthma attacks, providing actionable insights to clinical teams. This innovative approach aims to reduce emergency room visits by offering timely recommendations to patients, thereby redefining asthma management and enhancing overall care.

SageSurfer operates a mental healthcare platform designed to empower individuals in overcoming behavioral health challenges by fostering collaboration among their caregivers. The platform facilitates comprehensive, coordinated, and outcome-driven personalized care for mental health and addiction treatment. It enables consumers to actively participate in their care planning, ensuring they have a stronger voice in their treatment process. By centering the consumer in the recovery plan and providing access to their entire care team, SageSurfer aims to create a supportive healthcare environment where individuals are not alone in their journey towards recovery and can easily access help when needed.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

Phase Scientific is a biotech firm that creates diagnostic and data tools to help healthcare providers and patients. They provide tools for cancer, oncology, nipt, molecular diagnostics, NGS, dd PCR, point of care, liquid-phase extraction, sample preparation, purification, enrichment, size selection, cell-free DNA, cfDNA extraction, RNA extraction, viral RNA extraction, DNA methylation, library preparation, and liquid biopsy.

At SIPPA Solutions, we build technology to empower individuals with tools to securely exchange and consolidate health data with privacy assurance, and to transform their data to actionable plan for achieving self-management and personalized healthcare.

Aipiphany is a provider of innovative AI-driven solutions designed to enhance patient education and engagement within healthcare settings. By leveraging advanced algorithms and machine-learning techniques, Aipiphany's platform, Aipiphany Notes, transforms physicians' electronic health record (EHR) notes into accessible, interactive tools for both staff and patients. This approach fosters collaboration between patients and healthcare providers, promoting shared ownership of health outcomes. The platform personalizes medical content delivery based on patients' individual beliefs and perceptions, enabling them to better understand medical terminology and improve their overall care. By enhancing medication adherence and reducing readmission rates, Aipiphany aims to democratize medical knowledge and empower patients in their healthcare journeys.

Elidah, Inc. is a medical device company based in Monroe, Connecticut, that focuses on addressing urinary incontinence in women. Founded in 2015, the company has developed Elitone, a non-invasive device designed to stimulate and strengthen pelvic floor muscles. This device utilizes an external electrode placed in the perineal region to transmit a microcurrent, effectively toning the pelvic floor muscles and providing women with greater control over their bladders. By offering a practical solution for both stress and urge incontinence, Elidah aims to empower women to maintain an active lifestyle without the anxiety of leaks or frequent bathroom trips.

Bold Diagnostics is a medical device startup focused on developing an innovative diagnostic platform for blood pressure monitoring. The company has created a device that optimizes hypertension and pressure management by utilizing a novel parameter to derive noninvasive, cuffless blood pressure measurements. This pocket-sized device allows for ambulatory cardiovascular diagnostics, providing both patients and physicians with an accurate, comfortable, and convenient alternative for measuring and monitoring blood pressure. Through its technology, Bold Diagnostics aims to enhance the management of cardiovascular health.

Aluna is focused on empowering patients with chronic respiratory conditions, particularly asthma, by providing tools for better understanding and management of their lung health. The company has developed a portable spirometer device that utilizes machine learning and integrates with a mobile app. This technology allows patients to take daily measurements of their asthma, track symptoms, medication use, exercise, and environmental factors. By objectively monitoring asthma severity, the device enables healthcare providers to detect early signs of asthma attacks and create personalized, real-time action plans for their patients. Aluna is committed to enhancing the quality of life for individuals with asthma through innovative medical devices and healthcare solutions.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

VoluMetrix is dedicated to developing breakthrough monitoring technologies to enhance people's well-being. VoluMetrix partners closely with patients and practitioners to develop the pathway towards the optimal implementation and utilization of their technology, from hospital to home.

AbiliLife is a company dedicated to designing and developing products to improve the quality of life for patients with Parkinson's and other neurodegenerative diseases.

WiseWear is an award-winning Internet of Things (IoT) company that designs and develops a range of connected devices and services aimed at enhancing health, safety, and security for families. By integrating proprietary biosensing and wireless communication technologies into everyday items, WiseWear makes technology seamlessly blend into daily life. The company's devices track human activities and can send notifications to emergency contacts in critical situations, as well as provide mobile alerts for important calls, texts, and reminders. This innovative approach allows consumers to effectively manage their health and wellness while enjoying stylish and functional products.

Phase Scientific is a biotech firm that creates diagnostic and data tools to help healthcare providers and patients. They provide tools for cancer, oncology, nipt, molecular diagnostics, NGS, dd PCR, point of care, liquid-phase extraction, sample preparation, purification, enrichment, size selection, cell-free DNA, cfDNA extraction, RNA extraction, viral RNA extraction, DNA methylation, library preparation, and liquid biopsy.

Provider of an application to assess sleep quality and for identifying sleep disorders. The company provides a sleep analytic system which combines physiologic signals captured by microsensors and proprietary signal processing algorithms to provide reliable sleep quantity and quality

Sanguina is a medical device and wellness tool company that specializes in point-of-care diagnostics, particularly for hemoglobin determination. The company is focused on launching its first product, AnemoCheck Mobile, which is a non-invasive smartphone application designed for tracking hemoglobin levels without the need for painful blood draws. This innovative approach emphasizes anemia screening through color-based testing, allowing users to conveniently monitor their hemoglobin levels.

Elidah, Inc. is a medical device company based in Monroe, Connecticut, that focuses on addressing urinary incontinence in women. Founded in 2015, the company has developed Elitone, a non-invasive device designed to stimulate and strengthen pelvic floor muscles. This device utilizes an external electrode placed in the perineal region to transmit a microcurrent, effectively toning the pelvic floor muscles and providing women with greater control over their bladders. By offering a practical solution for both stress and urge incontinence, Elidah aims to empower women to maintain an active lifestyle without the anxiety of leaks or frequent bathroom trips.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

As passionate scientists, researchers, and innovators, we develop intuitive technology to manage existing health conditions and enable disease prevention through early detection. We recently launched the world's first mobile metabolism tracker, which has been featured in CNET, Forbes, Scientific American, BBC, PSFK, Fast Company, and other press.

CREmedical, founded in 2011 and headquartered in Kingston, Rhode Island, specializes in the development of electroencephalography equipment aimed at enhancing the understanding of brain function and aiding in the diagnosis and treatment of mental illnesses and brain disorders. The company's innovative devices monitor brainwaves and are designed to facilitate the recording of electroencephalograms (EEGs) in home settings. This technology not only assists healthcare professionals in detecting life-threatening events but also has the potential to prevent seizures, thereby improving patient care and outcomes.

At SIPPA Solutions, we build technology to empower individuals with tools to securely exchange and consolidate health data with privacy assurance, and to transform their data to actionable plan for achieving self-management and personalized healthcare.

Provider of an application to assess sleep quality and for identifying sleep disorders. The company provides a sleep analytic system which combines physiologic signals captured by microsensors and proprietary signal processing algorithms to provide reliable sleep quantity and quality

ChromaDex Corporation is a Los Angeles-based nutraceutical company focused on promoting healthy aging through its innovative products. The company is best known for its flagship ingredient, Nicotinamide riboside (NIAGEN), a form of vitamin B3 that enhances levels of nicotinamide adenine dinucleotide (NAD+), which naturally decline with age. In addition to NIAGEN, ChromaDex offers Immulina, a spirulina extract aimed at improving immune function. The company operates through three primary segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the Consumer Products segment generating the majority of revenue. ChromaDex markets its products directly in the United States and Canada, while also utilizing international distributors to reach a global audience. Through its in-house expertise in chemistry and regulatory compliance, ChromaDex develops and commercializes patented ingredient technologies for various industries, including dietary supplements, food and beverages, cosmetics, and pharmaceuticals.

Early skin health monitoring and care management system for wound care, dermatology, and cosmetics with initial application to the prevention of bedsores and diabetic foot ulcers. Mission: Rubitection's mission is to be the global standard system for skin health monitoring and care management for wounds and chronic dermatological skin conditions. Products: Rubitection's low cost easy to use hand held system that empowers anyone to monitor the health of their skin to identify a range of conditions early including bedsores, diabetic foot ulcers, vascular leg ulcers and chronic dermatological conditions.

Quick-Med Technologies, Inc. is a life sciences company dedicated to developing proprietary technologies aimed at infection prevention and control in both medical and consumer healthcare markets. Founded in 1997 and headquartered in Gainesville, Florida, the company specializes in biomedical products and devices with antibacterial applications. Its core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a series of advanced polymers with antimicrobial and hemostatic properties; Stay Fresh, a chemical formulation for textiles that provides durable antimicrobial protection; and MultiStat, which comprises patented methods and compounds for skin therapy. Quick-Med serves a diverse range of clients, including government agencies, healthcare providers, and companies in the apparel, textile, and personal care sectors.

CREmedical, founded in 2011 and headquartered in Kingston, Rhode Island, specializes in the development of electroencephalography equipment aimed at enhancing the understanding of brain function and aiding in the diagnosis and treatment of mental illnesses and brain disorders. The company's innovative devices monitor brainwaves and are designed to facilitate the recording of electroencephalograms (EEGs) in home settings. This technology not only assists healthcare professionals in detecting life-threatening events but also has the potential to prevent seizures, thereby improving patient care and outcomes.

BIORASIS was established in Dec. 2007 with an initial goal to commercialize UCONN’s and OSCI’s wireless, needle-implantable, miniaturized (0.5 x 0.5 x 5 mm) sensor platform for real time, continuous glucose monitoring. In addition to glucose monitoring Biorasis is working towards outfitting its sensor platform to monitor other bio-analytes in the body that are important in other disorders such as cardiovascular, cancer, liver, kidney abnormalities, stroke and epilepsy.